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Abstract
Development of the T cell lineage Is characterized by the homing of hematopoietic precursors to
thymus, followed by their acquisition of receptors for antigen. T cell receptors are a/3 or >5
heterodimers associated with CD3 (TCR - CD3). Very early T cell precursors in humans have been
characterized as CD7+45+ cells which lack the T cell differentiation antigens CD1, CD2, CD3,
CD4, and CD8. A phenotypically equivalent early thymocyte population also occurs In postnatal
life, and we have previously shown that interleukin 2 (IL2) promotes the development in vitro of
both the a/3 and the y5 T cells from these early thymocytes. Here we have analyzed the
requirements of the induction of the IL2 pathway In early thymocytes, and their developmental
potential. We show that: (I) thymic stromal cells, which are present In thymocyte suspensions,
are necessary to induce the IL2 pathway and the development of a/3 or 7<5 T cell lineages from
early thymocytes in vitro; and (II) when removed from the In vivo environment, early thymocytes
can develop In vitro into TCR-CD3- cells of the natural killer (NK) lineage. We conclude that
CD7+45+, CD1 - 2 - 3 - 4 - 8 - early thymocytes are multipotential progenitors that, at least, have the
capacity to develop into a/3 or yd T cell and NK lineages. The analysis of the mechanisms of
generation and selection of human T and NK cell diversity, not feasible In bone marrow cultures,
Is now possible.
Introduction
T cell precursors develop apart from the other hematopoietic
lineages within the thymic microenvironment (1,2). The
importance of the thymus for T cell precursor differentiation is
underscored by the severe T cell immunodeficiency, but not by
B or natural killer (NK) lymphocyte defects, suffered by athymic
individuals. The defects in the thymic microenvironment reside
in non-T lineage 'thymic stroma' cells, as shown by the
reconstitution of T cells after transplants of thymic stroma (3,4).
The recent characterization of monoclonal antibodies specific for
thymic stromal components (i.e. the distinct types of epithelial
and hematopoietic stroma; 5-7) provides the tools necessary
to study the role of the thymus in human T cell development in
vitro.
Experiments ex vivo have shown that T cell progenitors
colonize the human thymus at week 7 of gestation, before
development of any mature T cell. The colonizing cells are
hematopoietic cells (i.e. CD45+) that express an early T cell
marker, CD7, but lack other T cell differentiation antigens (5) In
postnatal life an equivalent CD7 + 45 + , CD1 - 2 - 3 - 4 - 8 -
mtrathymic population has been demonstrated (2). Hereafter, we
will refer to this population as early thymocytes, according to the
nomenclature originally proposed for human thymocyte
subpopulations by Reinherz and Schlossman (8).
Experiments in vitro have shown that distinct subpopulations
of human CD4-8- 'double-negative' thymocytes, such as early
thymocytes, are able to grow and differentiate into T cells by
culture in recombinant interleukin-2 (rll_2; 2,7,9,10). In the mouse,
development of mature T cells from double-negative thymocytes
is apparently not feasible in vitro (11). However, double-negative
thymocytes develop into mature T cells upon transfer in vivo if
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a thymus is present (11,12). Here we have analyzed whether
thymic stroma is required for the IL2-dependent in vitro
development of human early thymocytes. We have also studied
whether human early thymocytes are irreversibly committed to
the T cell lineage. We show that thymic stroma cells are present
in low numbers in populations of early thymocytes isolated by
negative selection of CD1, CD2, CD3, CD4, and CD8 antigen-
positive thymocytes. Such thymic stroma cells, absent from early
thymocytes which are carefully purified by positive selection, are
required both for IL2-dependent growth and the differentiation
into a£ and 76 T cells. We further show that early thymocytes
are a multipotential population able to develop into NK cells in
vitro.
Methods
Isolation of thymocyte populations
Single-cell suspensions were prepared from thymic fragments
that had been removed from patients 2 months-6 years old
during corrective cardiac surgery. Thymocytes expressing CD1,
CD2, CD3, CD4, or CD8 differentiation antigens were eliminated
by incubation with cytotoxic antibodies and rabbit complement
(Behringwerke, Marburg, FRG), as described elsewhere (10).
Viable thymocytes were isolated by Ficoll - Hypaque density
centrifugation. CD7 + , CD1 - 2 - 3 - 4 - 8 - early thymocytes were
separated from non-T lineage, stromal components using M-450
beads coupled with anti-CD7 antibodies and a sintered magnetic
alloy. Early thymocytes were then detached from the beads by
incubation at 37°C, before use in the experiments reported.
CD1 - 2 - 3 - 4 - 7 - 8 - thymocytes were used as a source of fresh,
autologous stromal cells. We followed the manufacturer's
recommendations (Dynal, Oslo, Norway) throughout the method.
The same protocol was used to enrich for mature thymocyte from
the total population, using M-450 beads coated with either Na1/34
(CD1, negative selection) or F10-44-2 (CD44, positive selection).
NK cells derived from early thymocyte cultures were isolated by
either cytotoxic elimination of TCR-CD3+ cells with OKT3
antibody and complement, or by positive selection of CD16 +
cells using M-450 magnetic beads coated with B73.1 antibody.
Monoclonal antibodies
CD1, Na1/34 (13); CD2, Leu-5 (Becton-Dickinson, Mountainview,
CA, USA) and CoulterClone T11 (Coulter, Hialeah, FL, USA),
CD3, OKT3 (American Type Culture Collection, ATCC, Bethesda,
MD, USA) and CoulterClone T3; CD4, HP2/6 (14) and
CoulterClone T4; CD7, 3A1 (ATCC) and RFT2 (15); CD8, B9.4
(16) and CoulterClone T8; CD11b, CoulterClone Mo1; CD14,
CoulterClone Mo2; CD16, Ieu11 (B73.1); CD20, CoulterClone
B1; CD45, D3/9 (17); a/3TCR/CD3, WT31 (Sanbio, Leiden, The
Netherlands); anti-7/61, TCR7/6 (18), DA4-4, IgM (ATCC); HNK-1,
Leu7; Coulter NKH1 and PTL-1; CD44 F10-44-2 (19); RFD1 (6);
and TE3A and TE4 (20, Serotec, Bicester, UK) were used.
Cell cultures
Cultures were maintained in RPMI 1640 medium supplemented
with 2 mM glutamine, 10 mM HEPES, and 10% human serum
(complement-depleted and pooled male AB donor), hereafter
referred to as complete medium. Cells (106) were cultured in
Cluster24 plates (Costar no. 3524, Cambridge, MA, USA) in
complete medium supplemented with ML2 (Hoffmann-LaRoche
Ltd, Basel, Switzerland) and/or autologous thymic stroma at 1:8
ratio of thymic stroma to early thymocytes or mature thymocytes.
Stroma cells were irradiated (2500 rad) to prevent their pro-
liferation in these complementation experiments Where indicated,
stroma cells were placed in the inner chamber of a Transwell
system (Costar no. 3408), separated from thymocytes by a
0.4 /tm pore, polycarbonate membrane. Cells in replicate cultures
were harvested after the indicated period of time, and aliquots
were used in immunofluorescence and cytotoxicity assays after
determination of the cellular recoveries. For proliferative assays,
10s cells were cultured for 4 days in the presence of the
indicated interleukins (50 U/ml) and [methyPHJthymidine
(Radiochemical Centre, Amersham, UK) was added at 1 /iCi/well
for the last 12 h of culture. rlL1a and rlL1/3, rlL3, and rlL4 were
generously provided by Hoffmann-LaRoche (Basel), Nippon-
Roche, (Kumamoto, Japan), and Sandoz (Basel) respectively
Quantitative flow cytometry
The procedure for indirect immunofluorescence surface staining
of the cells has been described (21) Staining of cytoplasmic
antigens was performed as described by Shoroff etal. (22).
Briefly, cell membranes were permeabilized with 10 /tg/ml
lysolecithin (Sigma, St Louis, MO, USA) for 2 mm at 4°C
Thereafter, they were processed as for cells undergoing surface
immunofluorescence. Fluorescein-conjugated goat anti-mouse
Ig (Southern Biothechology, Birmingham, AL, USA) was used
as a second step reagent. For two-color analyses, antibodies
were either directly labeled with fluorescein isothiocyanate (FITC,
green) or phycoerythrin (PE, orange-red), or biotin-conjugated
In the latter case, a second layer of avidin - FITC was added to
reveal the binding (2,23). Quantitation of the staining of 104
(one-color) or 5x1CH (two-colors) viable cells was performed
with a Coulter EPICS-C cell sorter or a FACScan analyzer, as
detailed elsewhere (23).
Cytotoxicity assays
Putative effector cells were tested for cytotoxicity against 5 x 103
5
'Cr-labeled K562 target cells at various effector/target ratios in
a 4 h siCr-release assay. Cytotoxic activity was calculated as
described elsewhere (24). Assays were carried out either in the
absence or presence of 75 ng/ml anti-CD3 antibody OKT3, using
heat-inactivated human AB sera.
Results
Phenotypic analyses of CD1 -2-3-4-8- thymocytes reveals
CD7+45+ early precursors and thymic stromal components
Our interest was to analyze the requirements for growth and
differentiation of the postnatal CD7+45+, CD1 - 2 - 3 - 4 - 8 - early
thymocytes. Therefore we treated total thymocytes with a mixture
of cytotoxic anti-T cell antibodies, specific for CD1, CD2, CD3,
CD4, and CD8, and complement. The phenotype of the
remaining population (0.3 ± 0.1%, n = 6) was further analyzed
in order to characterize the surface molecules potentially
expressed on these cells, as well as to quantify the percentage
of contaminating thymic stroma or hematopaetic cells from other
lineages. The thymocyte subset isolated contained < 1 % of
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CD1+, CD2 + , CD3 + , CD4 + , or CD8+ cells (Fig. 1b). Three
distinctive cell types were present,
(i) Most, but not all, cells (93%, Fig. 1c) expressed the leukocyte
Log F l u o r e s c e n c e In tens i ty
Fig. 1. Early thymocytes and thymic stroma are co-enriched after
negative selection of CD1, CD2, CD3, CD4, and CD8-posrtive thymocytes.
Thymocytes were treated with cytotoxic anti-T cell antibodies and com-
plement, and the phenotype of the surviving population was analyzed
by indirect immunofluorescence and quantitative flow cytometry in a
FACScan analyzer, as indicated in Methods Histograms show the
fluorescence profiles of viable cells labeled with (a) normal mouse serum;
(b) a cocktail of CD1, CD2, CD3, CD4, and CD8, (c) CD45, (d) CD7;
(e) TE3A plusTE4; (f) CD14, (g) CD16 plus NKH1 and HNK1, and (h)
CD20 plus anti-ji Vertical dotted lines indicate the limit chosen for
background fluorescence.
common antigen (LCA, CD45), which is normally present on
nucleated hematopoietic cells but not on other lineages, and the
majority of them wereCD7+ (~81%3A1 +, Fig. 1d). Thus, their
phenotype resembles that of the human fetal prethymic T cell
progenitor.
(n) Approximately 6% are epithelial thymic stroma cells, as
indicated by the binding of antibodies TE4 and TE3A to a minor
subset of the CD1 - 2 - 3 - 4 - 8 - cells (Fig. 1e).
(lii) Myelomonocytic CD14+ (Mo2) cells constitute a minor, but
sizeable (— 7%, Fig. 1f), portion of hematopoietic origin. At least
some of these cells are likely to represent thymic stroma
hematopoietic cells because of the detection of some positive
cells by the antibody RFD1, a reliable marker of interdigitating,
dendritic stroma cells (6, see below). Other hematopoietic
lineages, such as CD16 + , NKH-1+, and HNK-1 + NK cells
(Fig. 1g), or PLT-1 + platelets are undetectable (<1%). The
finding of a few B cells (Fig. 1h), as estimated by antibodies
specific for CD20 (B1) and surface IgM, is not surprising in view
of the existence of a small subset of B cells in normal thymus
(25; J. L. Andreu, personal communication).
The demonstration of thymic stromal components points to an
unsuspected shortcoming of negative selection approaches for
the isolation of T cell progenitors from postnatal 'thymocyte'
suspensions We therefore isolated cells bearing CD7 by positive
selection using magnetic beads coated with antj-CD7 antibodies.
Immunofluorescence and flow cytometry analyses of the purified
cells demonstrated that these positively selected cells are a
homogeneous population of CD7 + , CD1 - 2 - 3 - 4 - 8 - cells
(Fig. 2, left panels). In contrast, the CD1 - 2 - 3 - 4 - 7 - 8 -
thymocytes are a heterogeneous population that contains, at
least, the following thymic stroma cell types: TE4+/TE3A +
thymic epithelial cells, RFD1 + interdigitating cells, and
CD11b/Mac-1+ monocytes (Fig. 2, right panels). A clear
demonstration that CD1 - 2 - 3 - 4 - 7 - 8 - thymocyte suspensions
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Fig. 2. Early thymocytes can be separated from thymic stroma using anti-CD7 antibodies. Early thymocytes were sorted from non-T lineage, stroma
cells present in CD1 -2 3 - 4 - 8 - thymocyte suspensions using magnetic beads coated with anti-CD7 antibodies, and the phenotype of the separated
populations was analyzed by indirect immunofluorescence and flow cytometry, as described in Methods The profiles of immunofluorescence for
background staining (left) and for the indicated antigens (right) are superimposed for better comparison. Early thymocytes were labeled with either
CD7 or a mixture of CD1, CD2, CD3, CD4, and CD8 antibodies. Non-T lineage cells were labeled with RFD1 antibody, specific for interdigitating
cells, TE3A plus TE4 antibodies, specific for epithelial cells (20); CD11 b, staining monocytes; and a cocktail (CD1, CD2, CD3, CD4, CD7, and CD8)
of antibodies to the T lineage panel
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Fig. 3. Thymic stroma selectively induces IL-2 responsiveness in early
human thymocytes. Early thymocytes, and CD44+ or CD1 - thymo-
cytes, were sorted using magnetic beads coated with the specific anti-
bodies, as described in Fig 2 and Methods. 105 cells were cultured for
4 days in 96-well, flat-bottomed mcrotiter plates in the presence of 50 U/ml
of the indicated interieukins and either in the presence ( • ) or absence
( • ) of irradiated stroma cells Results show the uptake of [3H]thymidine
during the last 12 h of culture The experiment is representative of three
independent ones Standard deviations were < 1 1 % in the triplicate
cultures Note the different scale used for early and mature thymocytes
contain thymic stroma comes from the establishment of epithelial
cell lines from the suspensions reported here (A de la Hera,
unpublished observations). In view of these results, we wish to
stress that single-cell suspensions prepared from thymus contain
not only 'thymocytes' but, albeit in very low numbers, epithelial
and hematopoietic stromal cells.
Requirements for early thymocyte growth
In previous studies in the human system, different subsets of
CD4-8- thymocytes isolated by negative selection have been
shown to produce and use IL2 to grow autonomously and
differentiate into T cells (7,9,10,21,24). Considering the central
role played by the thymic microenvironment in the development
of T cells, rt seemed unwarranted to assume that the requirements
for growth and differentiation of mixed populations of early
thymocytes and stroma cells are the same as those for isolated
intrathymic T cell progenitors. We therefore studied the
proliferative responses of early thymocytes to recombinant
interieukins (from IL1a to IL4) in the presence or absence of
autologous thymic stroma.
Purified early thymocytes proliferate in rlL4 but not in rlL1o
or IL1/3. rlL2and rlL3 promoted some proliferation in these cells,
though to a much lesser degree than rlL4 (Fig. 3, filled bars).
The failure of rll_2 to promote proliferation of positively selected
earty thymocytes contrasts with the proliferative responses of early
thymocytes enriched by negative selection (2). In comple-
mentation experiments, mixing purified early thymocytes and
irradiated stroma cells, a strong proliferative response to rll_2 was
observed, showing that the IL2 unresponsiveness of early
thymocytes is not due to a non-specific suppression caused by
the binding of CD7 antibodies (Fig. 3, open bars). Since stroma
cells fail to induce significant IL2 responsiveness in either
CD44+ or CD1 - thymocytes (enriched in mature T cells, refs 2,
5), this complementation is not due to a non-specific
enhancement of proliferation by stromal cells. The reduced
proliferation of early thymocytes of IL2 after their separation from
stroma does not reflect a non-specific 'filler defect' since their
proliferation to rlL4 did not require the addition of stroma. IL4
responsiveness might thus precede IL2 responsiveness in the
human, as it appears to with mouse prethymic PRO-T cells (1)
We conclude that thymic stroma cells selectively promote IL2
responsiveness of early thymocyte in vitro
Early thymocytes can develop into either a/3 and yd T cell or
NK cell lineages
A requisite for a putative intrathymic T cell precursor is the ability
to differentiate into mature cells (1). In our study on human T cell
precursors we took advantage of the inducibility of the IL2
pathway in early human thymocytes (2) and the existence of
monoclonal antibodies to framework determinants of a/3 and y&
TCRs. Here we explored the differentiation potential of positively
selected early thymocytes cultured in IL2 in either the presence
or absence of stroma cells. As a readout for differentiation, two-
color immunofluorescence and flow cytometry were used to
distinguish and charactenze the putative progeny separately from
their precursors The CD7 + 45 + , CD1 - 2 - 3 - 4 - 8 - phenotype
was maintained by the cultured population during the initial 3 - 4
days of culture without any detectable T cell progeny. After this
lag period, early thymocytes started to develop into T cells.
Remarkably, the TCR - CD3 complex, whether ajS or y8, was first
expressed in CD2 + , CD4-8- double-negative thymocytes at
days 3 -4 . Single-positive CD4+ or CD8+ cells first appeared
in the cultures at day 5, and accumulated thereafter. Either a/3
or y5 TCR-CD3 was expressed in these single-positive
thymocytes. These results are illustrated in Fig. 4 with two color
contour plots obtained at day 7, when all subsets were present
in significant numbers. Direct contact between early thymocytes
and stroma cells was required for T cell development, since if
stroma cells were present in the well but separated from the
thymocytes by a micropore membrane, no TCR-CD3
expression was induced in early thymocytes cultured in 50 U
rll_2 for 1 week (data not shown). From these results, we conclude
that human early thymocytes exposed in vitro to the influence
of thymic stromal elements and rlL2 have the potential to develop
into the T cell lineage expressing both types of CD3-associated
TCR.
In addition, populations of CD11b+ (Mac-1), CD16+ (FcR7),
HNK1+, and NKH1+ cells also developed in these cultures.
This combination of differentiation antigens is currently used to
define NK lymphocytes (23,26) The small amounts of
CD11 b/CD14+ monocytes, as well as the B cells initially present
in the mixed population of early thymocytes and stroma cells,
were gradually diluted by the expanding population of early
thymocytes and their progeny, and represented ^ 1 % after
1 week of culture. The distribution of 'NK markers' and CD3 in
the progeny of early thymocytes is illustrated in Fig 5. Most
CD16+ lymphocytes were CD3- cells, and thus not
TCR-CD3+ T cells The finding of some CD3+ cells express-
ing either HNK1 or NKH1 antigens is not unique to this in vitro
development system. It further reflects the existence in vivo of
minor subpopulations of lymphocytes within the T cell lineage
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Fig. 4. Development of a/3 and y6 T cells from human early thymocytes. Early thymocytes were cultured for 7 days in the presence of 50 U/ml
rlL2 and irradiated stroma cells Aiiquots of the cultures were stained for two-color analyses of the indicated antigens using antibodies labeled with
either FITC (green) or PE (red) fluorochromes Antibodies specific for CD antigens were directly conjugated (Coulter), TCRafS WT31 and TCR>5
anti-y/51 were biotinylated and the binding revealed by FITC-avidin (Becton-Dtckinson) Contour plots depict the two color immunoflorescence
distribution recorded by an EPICS-C cell-sorter equipped with a three-decade logarithmic amplifier. Dotted lines indcate background immunofluorescence
for each color obtained with isotype-matched irrelevant, control antibodies (Coulter), as indicated elsewhere (10,22)
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Rg. 5. Human early thymocytes have the potential to develop into phenotypically defined NK cells. Early thymocytes were cultured for 7 days
and labeled for two-color immunofluorescence, as indicated in Fig. 4. Directly labeled antibodies were obtained from Coulter (CD3 and NKH1) or
Becton-Dickinson (CD16 and NKH1). Three dimensional isometnc displays show the distribution of the green fluorescence in the x-axis (CD16, CD3
and CD3, respectively), of the red fluorescence in the y-axis (CD3, NKH1 and HNK1), and the number of cells accumulated is depicted in the vertical
z-axis Plots were generated using an EPICS-C cytometer and V2.2 software (Coulter).
exhibiting NK activity (27). Consistent with the view that the
CD3-16+ cells may represent NK but not T lymphocytes
(23,26), both CD3- and CD16+cultured early thymocytes kill-
ed K562 target cells in a 4 h 51Cr-release assay. Their cytotox-
icity was not modified by anti-CD3 antibodies, which induce
strong cytotoxic activity in a CD3+16- T cell clone (Fig 6)
Discussion
These analyses of the requirements for the growth and the
differentiation potential of CD7 + 45 + , CD1 - 2 - 3 - 4 - 8 - early
thymocytes in vitro have revealed that: (i) their IL2 responsiveness
requires the presence of thymic stroma cells; and (ii) at a minimum
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Fig. 6. The CD3 -16 + progeny of early thymocytes have the functional
features of NK cells. Aliquots of CD16+ ( • ) or CD3" ( • ) cells were
sorted from the cultures of early thymocytes described in Figs 4 and 5,
using magnetic beads coated with CD16 antibody or 0KT3 antibody and
complement respectively. Their cytotoxic activity was measured against
51Cr-labeled K562 target cells, either uncoated or coated with anti-CD3
antibody OKT3 A CD3 + 16- T cell clone ( • ) was used as an internal
control in these experiments. It was expanded from peripheral blood using
PHA, rll_2, and irradiated peripheral blood thymocytes, according to
standard protocols (18) Displays show the specific 51Cr release in a 4
h assay, at the indicated effector-to-target ratios. Spontaneous release
was <14% in both cases
they have the potency to develop into a/3 or yb T cells or
TCR-CD3- NK cells. Two controversial issues merit discussion
before considering the relevance of these results to the
proliferation and differentiation of T cell progenitors in vivo: (i)
whether early thymocytes use IL2 for their development, and (ii)
what are the precursor-product relationships among early
thymocytes and a/3 T cells, yd T cells, and the NK cell lineage.
The first controversy concerns the question of whether the T
cell development is promoted by IL2. Our studies in vitro suggest
tht the IL2-IL2 receptor pathway might be implicated in the
proliferation of functional a/3 or y8 TCR-CD3+ T cell precursors
(2) after the contact of the early thymocyte progenitor with stroma
cells, as it appears to with the ontogeny of mouse single-positive
a/3TCR + thymocytes in vivo (28). We have shown that when
stroma cells are not deliberately removed, different subsets of
human double-negative, but not mature, thymocytes
autonomously use the IL2 pathway for their growth and
differentiation into T cells (10,21). The discrepant observations
regarding the use of the IL2 pathway by double-negative
thymocytes (reviewed in ref. 2) might thus be explained by the
concomitant enrichment in some experiments for thymic stroma
accessory cells (7,9,10,21). In addition there are thought to
be distinct subsets of double-negative thymocytes in terms of
their IL2 responsiveness (11,42). Enrichment for the 'early'
CD7+45 + , CD1 - 2 - 3 - 4 - 8 - thymocytes may well allow the IL2
responsiveness of this population to be expressed in vitro. In the
mouse, phagocytic cells of thymic stroma but not spleen stroma
have functional IL2 receptors (29). Thymic stromaJ cells were not
the source of proliferating cells in our assays because they were
irradiated before they were used in complementation experi-
ments. Additional experiments are underway to study whether
the effects of IL2 in T cell development (2,27,29) are mediated
directly on the early thymocyte, indirectly via thymic stroma, or
both.
Our studies in vitro suggest that T cell differentiation requires
early thymocyte-to-stroma contact; what might the requirement
for cell-tc-cell contact be due to7 In the absence of thymic stroma,
some combinations of lymphokines can promote mouse PRO-T
cell growth without T cell differentiation. PRO-T cells will
differentiate into TCR-CD3+ T cells upon intrathymic injection
(1). Using this approach we have recently established clones of
human CD7 + , CD1 - 2 - 3 - 4 - 8 - thymocytes which do not
further differentiate into T cells despite the fact that they respond
to IL2 with proliferation (our unpublished observations). Thus, the
activation of IL2 or other known lymphokine pathways does not
itself promote T cell development (1). There are some, not
exclusive, possible mechanisms that could account for this. T
cell precursor - stroma interaction may trigger surface receptors
that raise second messages to activate the T cell development
program, or promote the production of soluble 'differentiation'
factors by stromal cells to which T cell precursors become
responsive after the cell-to-cell contact
The second controversy concerns the precursor-product
relationships in the thymus Our data suggest that the early
thymocytes are the precursors for both the T and NK cells
detected in vitro and that CD4+8+ double-positive thymocytes
are not an obligatory intermediate in the development of a/3
TCR-CD3+ T cells. It could be argued that the T and NK cells
detected in vitro are actually an outgrowth of residual mature
lymphocytes but we have seen that mature thymocytes fail to
proliferate under conditions that allow the early thymocytes to
develop (Fig. 3). Moreover, recent analyses of the plating
efficiency and phenotype of the progeny of single early
thymocytes are in general agreement with the results reported
here for bulk cultures (10). The possibility that contaminant blood
NK cells are the source of NK cells in the culture can also be
ruled out. NK cells do not proliferate under these culture
conditions In fact they are completely overgrown by
TCR-CD3+ cells after day 7 of culture in 50 U rlL2/ml (23,30).
We find that a/S TCR is expressed before CD4 or CD8 (Fig 4b,
d and e). This is thought to be unusual because comparative
analyses of TCRa/3 ontogeny in normal mouse have detected
V08-CD3+4-8- cells in newborns but not in fetuses (28,31).
These cells were considered to be late arrivals with no precursor
potential. However, such V08-CD3+4-8- thymocytes are
readily evident in female fetuses from anti-HY a/3 TCR transgenic
mice before CD4 and CD8 expression (H. von Boehmer, personal
communication). Thus, if a/3 TCR-CD3 + 4 -8 - thymocytes
behave in vivo as a rapidly switching transit population for CD4
or CD8 cells, as they appear to do in vitro (2), their existence
in fetuses might have been difficult to detect. Of course the
possibility still exists that an accelerated rate of surface expres-
sion for TCR chains, due to inductive microenvironment (i.e.
thymic stroma + rll_2 or the rearranged transgene respectively),
allows a() TCR acquisition before CD4/CD8 expression.
Yet another odd finding is the production of mature 76 bearing
T cells that express either CD4 or CD8 antigens (Fig 4b, d and
f). However, these are not an artefact from development in vitro,
but have also been recently identified ex vivo in humans (18;
P. Aparicio et al., submitted). In view of these results, the role
of these accessory molecules in the yd T cell lineage needs to
be reassessed
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Our studies suggest that T and NK cells may have a common
precursor. Other authors have also suggested the existence of
a common precursor for T and NK cells, to explain a common
T and NK defect in a type of human SCID (32). Moreover, studies
of human thymomas have revealed that treatment of lymphomas
of early thymocytes can cause the remission of the thymoma but
can also be accompanied by the onset of clonally related myelad
leukemias in the patient (33,34). In addition, erythro- and
myelopoiesis occurs in normal human thymus (35). In the mouse,
recent in vivo transfer studies further support the view that
negative selected Ly1duS Lyt2- L3T4- thymocytes can act as
precursors for both T and NK cells (36). Also a subset of mouse
Lyt2- L3T4- la- Mac-1 - thymocytes contains stem cells and
differentiates in vitro into macrophage/dendritic cells (37). Thus,
early thymocytes have the potential to be precursors, at least,
for distinct lymphoid lineages: a/3 or yS T and NK cells, and
perhaps for other hematopoietjc cell lineages. Two non-exclusive
possibilities may account for these results: (i) pluripotential stem
cells or committed precursors for every lineage reach the thymus;
and (ii) the early thymocyte population contains a common
precursor for the T and NK cell lineages. Whereas the expression
of CD34 (a putative differentiation antigen in human
hematopoietic stem cells) in a portion of early T cell precursors
from bone marrow and thymus or the finding of CD7 in NK cells
are consistent with those possibilities (38, our unpublished
observations), quantitative analyses for these progenitors,
conducted at the single cell level, would be required to definitively
solve this issue.
Concluding remarks
Cell lineage studies are a fundamental step in the analyas of every
developmental system. They delineate the basic differentiation
events in the ontogeny of a cell type A knowledge of the normal
fate of a progenitor cell allows one to assess its potency outside
the normal environment, thus ascertaining when cells are
irreversibly committed to a given fate (reviewed in ref. 39). Signals,
as yet unknown, provided by thymic stromal components, are
required both for the growth of early thymocytes in rlL2 and their
acquisition of TCR -CD3. In retrospect, this is not surprising in
view of the need for a thymus for T cell development and the
in vivo fate of early thymocytes. Along the above lines, we take
the development of NK cells in vitro as an indication that a subset
of early thymocytes is not irreversibly committed to T cell lineage,
and we are providing an in vitro microenvironment 'leaky' for
the development of this distinct lineage.
The present study points out that, besides soluble factors, cell-
to-cell contacts with accessory cells are necessary for the
developmental decisions that determine commitment to a given
lineage during human thymocyte differentiation. Dexter and
Whitlock - Witte cultures support development in vitro of erythrad,
myeloid, and B cell but not T cell lineages (40,41). This report
indicates that complementary culture systems may be developed
for studying the mechanisms for the generation and selection
of diversity in the T and NK cell lineages.
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